$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

$rmti Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000162828021010541 Filed on May 17, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$15.47M	$15.86M
YoY Change	-2.42%	1.91%
Cost Of Revenue	$15.07M	$14.74M
YoY Change	2.22%	1.34%
Gross Profit	$401.0K	$1.113M
YoY Change	-63.97%	10.16%
Gross Profit Margin	2.59%	7.02%
Selling, General & Admin	$5.774M	$7.346M
YoY Change	-21.4%	-21.2%
% of Gross Profit	1439.9%	660.02%
Research & Development	$1.809M	$1.822M
YoY Change	-0.71%	266.4%
% of Gross Profit	451.12%	163.7%
Depreciation & Amortization	$202.0K	$209.0K
YoY Change	-3.35%	11.45%
% of Gross Profit	50.37%	18.78%
Operating Expenses	$7.583M	$9.168M
YoY Change	-17.29%	-6.64%
Operating Profit	-$7.182M	-$8.055M
YoY Change	-10.84%	-8.57%
Interest Expense	$581.0K	$102.0K
YoY Change	469.61%
% of Operating Profit
Other Income/Expense, Net	-$570.0K	$71.00K
YoY Change	-902.82%	-45.97%
Pretax Income	-$7.752M	-$7.980M
YoY Change	-2.86%	-8.06%
Income Tax
% Of Pretax Income
Net Earnings	-$7.752M	-$7.984M
YoY Change	-2.91%	-8.01%
Net Earnings / Revenue	-50.1%	-50.35%
Basic Earnings Per Share	-$0.91	-$0.12
Diluted Earnings Per Share	-$0.91	-$0.12
COMMON SHARES
Basic Shares Outstanding	8.508M shares	67.52M shares
Diluted Shares Outstanding	8.508M shares	67.52M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$46.14M	$48.90M
YoY Change	-5.65%	75.9%
Cash & Equivalents	$35.68M	$37.40M
Short-Term Investments	$10.46M	$11.50M
Other Short-Term Assets	$2.389M	$1.760M
YoY Change	35.74%	4.76%
Inventory	$4.117M	$4.293M
Prepaid Expenses
Receivables	$6.597M	$4.587M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$59.24M	$59.49M
YoY Change	-0.42%	48.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.472M	$2.430M
YoY Change	1.72%	-56.45%
Goodwill	$921.0K	$920.7K
YoY Change	0.03%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$629.0K	$560.6K
YoY Change	12.2%	-72.79%
Total Long-Term Assets	$10.21M	$7.332M
YoY Change	39.21%	-14.34%
TOTAL ASSETS
Total Short-Term Assets	$59.24M	$59.49M
Total Long-Term Assets	$10.21M	$7.332M
Total Assets	$69.45M	$66.83M
YoY Change	3.93%	37.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.307M	$3.123M
YoY Change	5.89%	-30.9%
Accrued Expenses	$4.032M	$6.160M
YoY Change	-34.55%	-22.52%
Deferred Revenue	$2.170M	$2.179M
YoY Change	-0.43%
Short-Term Debt	$0.00	$190.0K
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.23M	$13.36M
YoY Change	-15.91%	-15.08%
LONG-TERM LIABILITIES
Long-Term Debt	$21.04M	$20.68M
YoY Change	1.73%
Other Long-Term Liabilities	$11.00M	$11.01M
YoY Change	-0.11%	-14.32%
Total Long-Term Liabilities	$21.04M	$20.68M
YoY Change	1.73%	60.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.23M	$13.36M
Total Long-Term Liabilities	$21.04M	$20.68M
Total Liabilities	$43.27M	$45.05M
YoY Change	-3.95%	57.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$345.2M	-$314.5M
YoY Change	9.76%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$26.18M	$21.77M
YoY Change
Total Liabilities & Shareholders Equity	$69.45M	$66.83M
YoY Change	3.93%	37.08%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$7.752M	-$7.984M
YoY Change	-2.91%	-8.01%
Depreciation, Depletion And Amortization	$202.0K	$209.0K
YoY Change	-3.35%	11.45%
Cash From Operating Activities	-$12.50M	-$6.538M
YoY Change	91.11%	20.55%
INVESTING ACTIVITIES
Capital Expenditures	-$38.00K	-$200.0K
YoY Change	-81.0%	66.67%
Acquisitions
YoY Change
Other Investing Activities	-$474.0K	$2.790M
YoY Change	-116.99%	-24.59%
Cash From Investing Activities	-$512.0K	$2.586M
YoY Change	-119.8%	-27.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$8.000M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	$29.56M
YoY Change	-100.0%	56230.16%
NET CHANGE
Cash From Operating Activities	-$12.50M	-$6.538M
Cash From Investing Activities	-$512.0K	$2.586M
Cash From Financing Activities	$0.00	$29.56M
Net Change In Cash	-$13.01M	$25.61M
YoY Change	-150.8%	-1526.89%
FREE CASH FLOW
Cash From Operating Activities	-$12.50M	-$6.538M
Capital Expenditures	-$38.00K	-$200.0K
Free Cash Flow	-$12.46M	-$6.338M
YoY Change	96.54%	19.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001041024
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	000-23661
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	ROCKWELL MEDICAL, INC.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3317208
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	30142 S. Wixom Road
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Wixom
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48393
CY2021Q1	dei	City Area Code CityAreaCode	248
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	960-9009
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001
CY2021Q1	dei	Trading Symbol TradingSymbol	RMTI
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	93628731	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35675000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48682000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	10464000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9997000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6597000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4171000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	4117000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	3913000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2389000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2706000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	59242000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	69469000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2472000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2642000	USD
CY2021Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	1325000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1176000	USD
CY2021Q1	rmti	Operating Lease And Finance Lease Right Of Use Assets Net OperatingLeaseAndFinanceLeaseRightOfUseAssetsNet	4860000	USD
CY2020Q4	rmti	Operating Lease And Finance Lease Right Of Use Assets Net OperatingLeaseAndFinanceLeaseRightOfUseAssetsNet	2911000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	921000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	921000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	629000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	629000	USD
CY2021Q1	us-gaap	Assets Assets	69449000	USD
CY2020Q4	us-gaap	Assets Assets	77748000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3307000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4155000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4032000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5013000	USD
CY2021Q1	rmti	Operating Lease And Finance Lease Liability Current OperatingLeaseAndFinanceLeaseLiabilityCurrent	1417000	USD
CY2020Q4	rmti	Operating Lease And Finance Lease Liability Current OperatingLeaseAndFinanceLeaseLiabilityCurrent	1167000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2170000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2175000	USD
CY2021Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	135000	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	152000	USD
CY2021Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	171000	USD
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	131000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	11232000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12793000	USD
CY2021Q1	rmti	Operating Lease And Finance Lease Liability Noncurrent OperatingLeaseAndFinanceLeaseLiabilityNoncurrent	3522000	USD
CY2020Q4	rmti	Operating Lease And Finance Lease Liability Noncurrent OperatingLeaseAndFinanceLeaseLiabilityNoncurrent	1821000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	21041000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	20949000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7476000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	8015000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	43271000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	43578000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2020Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93599519	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93599519	shares
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15072000	USD
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93573165	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93573165	shares
CY2021Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	9000	USD
CY2020Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	9000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	371274000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	371510000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-345158000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-337406000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	53000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	57000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	26178000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	34170000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	69449000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	77748000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15473000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15857000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14744000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	401000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	1113000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1809000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1822000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1851000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2073000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3923000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5273000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7182000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8055000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	2000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	581000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	102000	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	11000	USD
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	171000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-570000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	71000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7752000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-7984000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93591053	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93591053	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67518240	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	67518240	shares
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7752000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-7984000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7756000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7985000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	34170000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7752000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-236000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	26178000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	20320000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-7984000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8003000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	202000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	501000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	935000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	21774000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7752000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-7984000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	209000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-236000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	935000	USD
CY2021Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	71000	USD
CY2020Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	0	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	412000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	391000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	92000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	15000	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-6000	USD
CY2020Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	2000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3000	USD
CY2020Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2426000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	384000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	424000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	828000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-317000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1093000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-848000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	105000	USD
CY2021Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	0	USD
CY2020Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	-47000	USD
CY2021Q1	rmti	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-410000	USD
CY2020Q1	rmti	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-339000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-958000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	738000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-544000	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-446000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	5293000	USD
CY2020Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	108000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12495000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6538000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	7212000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	8872000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	6738000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	11661000	USD
CY2021Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	38000	USD
CY2020Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	203000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-512000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2586000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	22500000	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2020Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	374000	USD
CY2021Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2020Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	573000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29557000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13007000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	25605000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48682000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11795000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35675000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37400000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	485000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	81000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-7000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-7000	USD
CY2021Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2020Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	957000	USD
CY2021Q1	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2020Q1	us-gaap	Stock Issued1 StockIssued1	501000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	60000000	USD
CY2021Q1	rmti	Years Of Service YearsOfService	P25Y
CY2021Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	300	employee
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-345200000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	26200000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	46100000	USD
CY2021Q1	rmti	Working Capital Net WorkingCapitalNet	48000000.0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12500000	USD
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32885473	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13048405	shares
CY2021Q1	rmti	Number Of Distribution And License Agreements NumberOfDistributionAndLicenseAgreements	4	agreement
CY2021Q1	rmti	Average Payment Term Of Customers AveragePaymentTermOfCustomers	P30D
CY2021Q1	rmti	Average Payment Term Of Distributors AveragePaymentTermOfDistributors	P45D
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15473000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15857000	USD
CY2021Q1	us-gaap	Other Receivables OtherReceivables	6597000	USD
CY2020Q4	us-gaap	Other Receivables OtherReceivables	4171000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	9646000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10190000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Credit Loss Expense ContractWithCustomerAssetCreditLossExpense	0	USD
CY2020Q1	us-gaap	Contract With Customer Asset Credit Loss Expense ContractWithCustomerAssetCreditLossExpense	0	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	9600000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	10441000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	22000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	10464000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	9987000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	7000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9997000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3000	USD
CY2021Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3152000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3112000	USD
CY2021Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	312000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	172000	USD
CY2021Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1978000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1805000	USD
CY2021Q1	rmti	Current And Non Current Inventory CurrentAndNonCurrentInventory	5442000	USD
CY2020Q4	rmti	Current And Non Current Inventory CurrentAndNonCurrentInventory	5089000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9182000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9178000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6710000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6536000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2472000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2642000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	200000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	200000	USD
CY2021Q1	rmti	Research And Development Related Liabilities Current ResearchAndDevelopmentRelatedLiabilitiesCurrent	331000	USD
CY2020Q4	rmti	Research And Development Related Liabilities Current ResearchAndDevelopmentRelatedLiabilitiesCurrent	232000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1334000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2500000	USD
CY2021Q1	rmti	Accrued Unvouchered Receipts Current AccruedUnvoucheredReceiptsCurrent	661000	USD
CY2020Q4	rmti	Accrued Unvouchered Receipts Current AccruedUnvoucheredReceiptsCurrent	755000	USD
CY2021Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	436000	USD
CY2020Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	395000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1270000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1131000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4032000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5013000	USD
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93599519	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93599519	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93573165	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93573165	shares
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-236000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	935000	USD
CY2020Q1	rmti	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue	0	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	419000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	443000	USD
CY2018Q4	rmti	Number Of Additional Agreements NumberOfAdditionalAgreements	3	agreement
CY2021Q1	rmti	Related Party Transactions Accrued Reimbursement Of Ip Expenses And Sublicense Royalty Fees RelatedPartyTransactionsAccruedReimbursementOfIPExpensesAndSublicenseRoyaltyFees	200000	USD
CY2021Q1	rmti	Operating Lease And Finance Lease Liability OperatingLeaseAndFinanceLeaseLiability	4900000	USD
CY2021Q1	rmti	Operating Lease And Finance Lease Right Of Use Assets Net OperatingLeaseAndFinanceLeaseRightOfUseAssetsNet	4900000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3000000.0	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2900000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	102000	USD
CY2020Q1	us-gaap	Variable Lease Cost VariableLeaseCost	189000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	521000	USD
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	632000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	45000	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	USD
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	13000	USD
CY2020Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	USD
CY2021Q1	rmti	Finance Lease Expense FinanceLeaseExpense	58000	USD
CY2020Q1	rmti	Finance Lease Expense FinanceLeaseExpense	0	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	USD
CY2020Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	583000	USD
CY2020Q1	us-gaap	Lease Cost LeaseCost	636000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	425000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	445000	USD
CY2021Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	13000	USD
CY2020Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	37000	USD
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1896000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	460000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2021Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M12D
CY2020Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.063
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.068
CY2021Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.054
CY2020Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1107000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	199000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	455000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	269000	USD
CY2021Q1	rmti	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	79000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1083000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	269000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	740000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	272000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	555000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	270000	USD
CY2021Q1	rmti	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	272000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4019000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1551000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	417000	USD
CY2021Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	214000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3602000	USD
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1337000	USD

Files In Submission

Name	View Source	Status
0001628280-21-010541-index-headers.html	Edgar Link	pending
0001628280-21-010541-index.html	Edgar Link	pending
0001628280-21-010541.txt	Edgar Link	pending
0001628280-21-010541-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rmti-20210331.htm	Edgar Link	pending
rmti-20210331.xsd	Edgar Link	pending
rmti-202103310x10qex311.htm	Edgar Link	pending
rmti-20210331x10qex312.htm	Edgar Link	pending
rmti-20210331x10qex321.htm	Edgar Link	pending
rmti-20210331_cal.xml	Edgar Link	unprocessable
rmti-20210331_def.xml	Edgar Link	unprocessable
rmti-20210331_htm.xml	Edgar Link	completed
rmti-20210331_lab.xml	Edgar Link	unprocessable
rmti-20210331_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

2021 Q1 Form 10-Q Financial Statement

#000162828021010541 Filed on May 17, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI ROCKWELL MEDICAL, INC. Stock $rmti

2021 Q1 Form 10-Q Financial Statement

#000162828021010541 Filed on May 17, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti